MNX.V - Manitex Capital Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.1400
0.0000 (0.00%)
At close: 9:49AM EDT
Stock chart is not supported by your current browser
Previous Close0.1400
Open0.1400
Bid0.1700 x 0
Ask0.2500 x 0
Day's Range0.1400 - 0.1400
52 Week Range0.1400 - 0.4200
Volume5,000
Avg. Volume9,057
Market Cap1.759M
Beta (3Y Monthly)3.15
PE Ratio (TTM)N/A
EPS (TTM)-0.1940
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Manitex Capital Inc. Completes Distribution of Dividend-In-Kind Consisting of Warrants of Valeo Pharma Inc.

    KIRKLAND, QC, Aug. 28, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") is pleased to announce that it has completed the distribution to its shareholders of its previously announced special dividend-in-kind (the "Dividend") of share purchase warrants of Valeo Pharma Inc., ("Valeo Warrants") held by Manitex. The Dividend has a deemed price of $0.065 per Valeo Warrant and was distributed today to holders of record of common shares of Manitex ("Manitex Shares") at the close of business on August 9, 2019 (the "Record Date"), on a pro rata basis of 0.1 Valeo Warrant per Manitex Share.

  • CNW Group

    Manitex Capital Inc. declares a dividend-in-kind of warrants of Valeo Pharma Inc.

    KIRKLAND, QC, July 30, 2019 /CNW Telbec/ - Manitex Capital Inc. (TSXV:MNX.V - News), ("Manitex"), is pleased to announce that its Board of Directors has declared a special dividend-in-kind (the "Dividend") of 1,256,127 share purchase warrants of Valeo Pharma Inc. (the "Valeo Warrants") held by Manitex. The Dividend shall have a deemed price per Valeo Warrant based on the closing price of the Valeo Warrants (VPH.WT) on the Canadian Securities Exchange (the "CSE") on the trading day prior to payment of the Dividend, expected to occur on or about August 28, 2019, to holders of record of common shares of Manitex (the "Manitex Shares") at the close of business on August 9, 2019 (the "Record Date"). Based upon the number of Manitex Shares currently outstanding, and ignoring the effect of rounding for fractional interests, one Valeo Warrant will be paid under the Dividend for every 10 (ten) Manitex Shares (or 0.1 Valeo Warrants per Manitex Share) held on the Record Date.

  • Do Insiders Own Lots Of Shares In Manitex Capital Inc. (CVE:MNX)?
    Simply Wall St.

    Do Insiders Own Lots Of Shares In Manitex Capital Inc. (CVE:MNX)?

    If you want to know who really controls Manitex Capital Inc. (CVE:MNX), then you'll have to look at the makeup of its...

  • CNW Group

    Manitex Capital Inc. announces results of AGM

    KIRKLAND, QC, April 5, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex" or the "Company") is pleased to announce the voting results from its Annual General and Special Meeting of shareholders (the "Meeting") held today in Kirkland, Quebec. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 8,017,627 representing 63.83% of the Company's issued and outstanding shares.

  • Introducing Manitex Capital (CVE:MNX), The Stock That Zoomed 105% In The Last Five Years
    Simply Wall St.

    Introducing Manitex Capital (CVE:MNX), The Stock That Zoomed 105% In The Last Five Years

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you can make far more than 100%Read More...

  • CNW Group

    Manitex Capital Inc.'s affiliate, Valeo Pharma Inc., announces approval of Onstryv® (safinamide) for Canada

    KIRKLAND, QC, Jan. 15, 2019 /CNW Telbec/ - Manitex Capital Inc. (TSXV:MNX.V - News) announces that its affiliate, Valeo Pharma Inc., has received approval from Health Canada for a new Parkinson's Disease product ONSTRY® (safinamide) in Canada. Valeo Pharma plans to launch ONSTRYV® in Canada in the first half of 2019.

  • CNW Group

    Manitex Capital Inc. declares a dividend-in-kind of shares of Valeo Pharma Inc.

    KIRKLAND, QC, Jan. 11, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") is pleased to announce that its board of directors has declared a special dividend-in-kind (the "Dividend") of 1,256,127 common shares of Valeo Pharma Inc., ("Valeo") held by Manitex. The Dividend has a deemed price of $0.40 per Valeo Share and is payable on, or about, February 1, 2019 to holders of record of common shares of Manitex ("Manitex Shares") at the close of business on January 22, 2019 (the "Record Date").

  • CNW Group

    Manitex Capital Inc. announces director resignation

    KIRKLAND, QC , Nov. 21, 2018 /CNW Telbec/ - Manitex Capital Inc. (" Manitex " or the " Corporation ") announces that Mr. David Ben-David has resigned from its Board of Directors effective ...

  • Simply Wall St.

    Is Manitex Capital Inc’s (CVE:MNX) Balance Sheet Strong Enough To Weather A Storm?

    Investors are always looking for growth in small-cap stocks like Manitex Capital Inc (CVE:MNX), with a market cap of CA$4m. However, an important fact which most ignore is: how financially Read More...

  • CNW Group

    Manitex Capital Inc. Announces That Its Affiliate Valeo Pharma Inc. Has Filed a Non-Offering Preliminary Prospectus

    KIRKLAND, QC, Oct. 1, 2018 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") (TSXV:MNX.V - News) is pleased to announce that its affiliate, Valeo Pharma Inc. ("Valeo Pharma"), has filed a non-offering preliminary prospectus with the securities regulatory authorities of all provinces and territories in Canada. The non-offering prospectus is being filed for the purpose of allowing Valeo Pharma to become a reporting issuer in all jurisdictions of Canada and to become eligible for listing pursuant to the policies of the TSX Venture Exchange ("TSXV"). Listing will be subject to Valeo Pharma fulfilling all of the listing requirements of the TSXV.